Broadly Neutralizing Antibodies for HIV-1 Prevention or Immunotherapy

Authors:

Abstract
High serum titers of neutralizing antibodies develop in a small fraction of people who become infected with HIV-1. Isolation of such broadly neutralizing antibodies (bNAbs) has led to a new and promising approach to combat HIV-1 infection.